EBRO 2017

FDG-PET in the preoperative assessment of suspected non-small-cell lung cancer: PLUS trial

Conventional

Conventional workup + PET

workup (n=96)

(n=92)

No thoracotomy

18 (19%)

32 (35%)

confirmed N2/3

10

18

confirmed distant metastases

1 2 2 3

7 3 1 3

benign primary lesion

other tumor

intercurrent morbidity, refusal

Thoracotomy

78 (81%) 39 (41%) 39 (41%)

60 (65%) 41 (44%) 19 (21%)

non-futile thoracotomy

futile thoracotomy

benign

7 1 6 6

2 1 4 2

explorative thoracotomy

IIIA-N2

IIIB

recurrence or death < 1 year

19

10

Van Tinteren et al. Lancet 2002